title: Dialysis Surveillance Report: National Healthcare Safety Network (NHSN)-data summary for 2006.
abstract: Thirty-two outpatient hemodialysis providers in the United States voluntarily reported 3699 adverse events to the Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN) during 2006. These providers were previously enrolled in the Dialysis Surveillance Network. The pooled mean rates of hospitalization among patients with arteriovenous fistulas, grafts, permanent and temporary central venous catheters were 7.7, 9.2, 15.7, and 34.7 per 100 patient-months, respectively. For bloodstream infection the pooled mean rates were 0.5, 0.9, 4.2, and 27.1 per 100 patient-months in these groups. Among the 599 isolates reported, 461 (77%) represented access-associated blood stream infections in patients with central lines, and 138 (23%) were in patients with fistulas or grafts. The microorganisms most frequently identified were common skin contaminants (e.g., coagulase-negative staphylococci). In 2007, enrollment in NHSN opened to all providers of outpatient hemodialysis. Specific information is available at http://www.cdc.gov/ncidod/dhqp/nhsn_FAQenrollment.html.
authors.affiliation: Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, Georgia 30333, USA. rmk2@cdc.gov
authors.forename: R Monina
authors.initials: RM
authors.lastname: Klevens
authors.forename: Jonathan R
authors.initials: JR
authors.lastname: Edwards
authors.forename: Mary L
authors.initials: ML
authors.lastname: Andrus
authors.forename: Kelly D
authors.initials: KD
authors.lastname: Peterson
authors.forename: Margaret A
authors.initials: MA
authors.lastname: Dudeck
authors.forename: Teresa C
authors.initials: TC
authors.lastname: Horan
mesh_terms: D000553:Ambulatory Care; D016470:Bacteremia / Q000453:epidemiology* / Q000209:etiology; D002408:Catheters, Indwelling / Q000009:adverse effects*; D002487:Centers for Disease Control and Prevention, U.S.; D003428:Cross Infection / Q000453:epidemiology* / Q000209:etiology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D011159:Population Surveillance; D006435:Renal Dialysis / Q000009:adverse effects* / Q000706:statistics & numerical data; D012189:Retrospective Studies; D014481:United States / Q000453:epidemiology